Repligen
RGEN
#1836
Rank
S$14.31 B
Marketcap
S$225.44
Share price
-2.43%
Change (1 day)
7.97%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: S$14.31 Billion

As of October 2026 Repligen has a market cap of S$14.31 Billion. This makes Repligen the world's 1836th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$14.31 B19.15%
2025S$12.01 B8.38%
2024S$11.08 B-16.4%
2023S$13.25 B5.2%
2022S$12.60 B-36.34%
2021S$19.79 B42.7%
2020S$13.87 B113.59%
2019S$6.49 B105.24%
2018S$3.16 B49.68%
2017S$2.11 B40.08%
2016S$1.50 B14.45%
2015S$1.31 B53.77%
2014S$0.85 B55.41%
2013S$0.55 B130.3%
2012S$0.23 B73.57%
2011S$0.13 B-25.79%
2010S$0.18 B4.79%
2009S$0.17 B5.29%
2008S$0.16 B-42.41%
2007S$0.29 B123.57%
2006S$0.13 B-34.72%
2005S$0.20 B41.93%
2004S$0.14 B-36.43%
2003S$0.22 B54.14%
2002S$0.14 B20.03%
2001S$0.12 B-22.74%
2000S$0.15 B33.89%
1999S$0.11 B205.06%
1998S$38.07 M60.62%
1997S$23.7 M-10.35%
1996S$26.44 M

End of Day market cap according to different sources

On Oct 27th, 2026 the market cap of Repligen was reported to be:

S$11.02 Billion
by Nasdaq info icon info icon
S$14.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$217.80 B 1,421.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$328.59 B 2,195.75%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$396.04 B 2,666.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$161.22 B 1,026.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$39.31 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$2.11 B-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$19.03 B 32.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$14.59 B 2.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.73 B-4.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$21.96 B 53.48%๐Ÿ‡บ๐Ÿ‡ธ USA